PharmaEssentia Corporation (LUX:261280523)

PharmaEssentia Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,890	6,032	3,383	4,381	2,477	719
Market Cap Growth	-12.49%	78.30%	-22.77%	76.88%	244.49%	0.07%
Enterprise Value	4,330	5,449	2,800	4,274	2,462	612
Last Close Price	13.25	18.14	10.20	-	-	-
PE Ratio	36.40	69.04	-	-	-	-
PS Ratio	12.66	21.03	22.44	49.91	118.91	44.34
PB Ratio	5.88	7.45	4.78	11.85	18.37	6.30
P/TBV Ratio	5.93	7.53	4.84	12.08	19.50	6.68
P/FCF Ratio	57.81	121.51	-	-	-	-
P/OCF Ratio	40.53	80.38	-	-	-	-
EV/Sales Ratio	11.59	19.00	18.58	48.69	118.21	37.73
EV/EBITDA Ratio	37.68	100.14	-	-	-	-
EV/EBIT Ratio	41.00	106.51	-	-	-	-
EV/FCF Ratio	51.19	109.75	-	-	-	-
Debt / Equity Ratio	0.03	0.04	0.05	0.13	0.13	0.17
Debt / EBITDA Ratio	0.21	0.47	-	-	-	-
Debt / FCF Ratio	0.30	0.57	-	-	-	-
Asset Turnover	0.43	0.33	0.24	0.27	0.11	0.13
Inventory Turnover	1.22	0.86	0.48	0.83	0.60	1.15
Quick Ratio	6.45	9.34	9.86	4.37	2.80	3.37
Current Ratio	6.83	9.94	10.64	5.24	3.49	3.82
Return on Equity (ROE)	17.21%	11.54%	-3.46%	-16.77%	-68.81%	-63.10%
Return on Assets (ROA)	7.68%	3.72%	-5.61%	-11.77%	-30.08%	-25.26%
Return on Capital (ROIC)	8.46%	4.05%	-6.16%	-13.71%	-37.72%	-29.60%
Return on Capital Employed (ROCE)	12.80%	6.10%	-7.60%	-15.90%	-59.00%	-38.60%
Earnings Yield	2.75%	1.45%	-0.54%	-0.96%	-3.60%	-7.88%
FCF Yield	1.73%	0.82%	-1.74%	-1.26%	-3.24%	-6.22%
Dividend Yield	0.12%	0.16%	-	-	-	-
Buyback Yield / Dilution	-0.44%	-3.59%	-13.47%	-9.24%	-7.39%	-10.55%
Total Shareholder Return	-0.32%	-3.43%	-13.47%	-9.24%	-7.39%	-10.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.